Dr. David Kim -- Pharmaceutical Payment Report

This page provides a comprehensive transparency report for Dr. David Kim, a Allergy & Immunology physician based in Akron, OH. All payment data is sourced from the CMS Open Payments (Sunshine Act) database. Dr. David Kim has received $47,257.52 in total pharmaceutical industry payments across 1 transactions from 1 pharmaceutical companies.

Physician Profile

The following profile information is sourced from the National Provider Identifier (NPI) registry and CMS Open Payments records.

Payment Summary

Dr. David Kim has received a total of $47,257.52 in pharmaceutical industry payments across 1 recorded transactions in the CMS Open Payments database. The average payment amount is $47,257.52 per transaction.

Payment Breakdown by Category

The following table shows how Dr. David Kim's pharmaceutical payments break down by payment category. Understanding the mix of payment types provides important context about the nature of the doctor-pharma relationship.

Payment CategoryAmountDescription
Ownership Interest$47,257.52Ownership stakes, dividends, and investment returns

The largest payment category for Dr. David Kim is Ownership Interest, accounting for 100% ($47,257.52) of total pharmaceutical payments received. This indicates a financial ownership interest in a pharmaceutical or medical device company.

Pharmaceutical Company Relationships

The following pharmaceutical and medical device companies have made payments to Dr. David Kim. Click on any company name to view their full physician payment profile and spending patterns.

CompanyTotal PaidTransactions
Sanofi$47,257.521

Dr. David Kim has a financial relationship with Sanofi, receiving $47,257.52 in total. Having a single pharmaceutical company relationship means all payments come from one source, which may indicate a focused consulting or research relationship.

Drugs and Medical Devices Referenced in Payments

The following drugs and medical devices have been referenced in pharmaceutical payments to Dr. David Kim. These references indicate that the payment was related to the marketing, consulting, or clinical use of these products.

The presence of a drug or device in a payment record means the pharmaceutical company associated the payment with that product. This is common for consulting fees related to a specific medication, speaking engagements about a product, or research involving a particular drug or device.

AI Transparency Analysis

The following analysis was generated by artificial intelligence based on Dr. David Kim's payment history, specialty peer comparisons, and payment pattern analysis. This analysis is not medical or legal advice.

David Kim has received $47.3K across 1 pharmaceutical payments as a Allergy & Immunology physician in Akron, OH. Top paying companies include Sanofi ($47.3K). Dr. Kim received a single, substantial payment of $47,258 in 2025. This payment was entirely from Sanofi and categorized as 'ownership'. The payment is linked to the drug Tecfidera, indicating a potential relationship with its manufacturer.

Patient Guidance: Questions to Ask Your Doctor

If Dr. David Kim is your physician, here is practical guidance on how to understand and discuss pharmaceutical industry relationships:

When discussing treatments with your doctor, consider asking about any financial relationships they may have with pharmaceutical companies or specific medications. Always feel free to ask your doctor directly about their pharmaceutical relationships.

Peer Comparison: How Dr. David Kim Compares to Other Allergy & Immunology Physicians

For Allergy & Immunology specialists, payment profiles vary, but significant single payments, especially those related to ownership, warrant attention.

Recent Payment Records

The following table shows the most recent pharmaceutical industry payments recorded for Dr. David Kim in the CMS Open Payments database. Click on any payment to view the full report.

CompanyAmountTypeDrug/DeviceDateConflict Level
Sanofi$47,257.52ownershipTecfidera2025-10-10Not Assessed

Frequently Asked Questions About Dr. David Kim's Pharma Payments

Below are common questions patients ask about physician pharmaceutical payment data.

How much pharma money has David Kim received?

David Kim has received a total of $47.3K across 1 payments from pharmaceutical companies. This data is publicly reported under the CMS Open Payments (Sunshine Act) program.

Is David Kim taking too much pharma money?

David Kim has received $47.3K in pharmaceutical payments. Whether this is "too much" depends on the physician's specialty (Allergy & Immunology), the types of payments, and how they compare to peers. The largest payment category is ownership ($47.3K). Payment does not imply wrongdoing, but patients should be aware and can ask their doctor directly.

What pharma companies pay David Kim?

The top pharmaceutical companies paying David Kim are: Sanofi ($47.3K). These payments cover various categories including consulting, meals, speaking fees, and research grants.

What kinds of payments does David Kim receive?

David Kim's payments by type: ownership: $47.3K.

Should I switch doctors because of pharma payments?

Pharma payments alone are not typically reason to switch doctors. Many payments are routine (like meals at educational events) and do not indicate compromised care. Focus on: (1) whether your doctor explains treatment options clearly, (2) whether generic alternatives are discussed, (3) the overall pattern of payments, not individual transactions. If you have concerns, ask your doctor directly.

How do David Kim's payments compare to other Allergy & Immunology doctors?

To compare, look at the total amount ($47.3K), number of payments (1), and the types of payments received. Allergy & Immunology physicians may receive different payment amounts depending on subspecialty, geographic location, and academic affiliation. Use CMS Open Payments data to compare across the specialty.

How can I verify David Kim's payment data?

You can verify this data directly through the CMS Open Payments database at openpaymentsdata.cms.gov. Search by physician name or NPI number (1267645098). All data is reported by pharmaceutical companies and verified by CMS. DoctorPharmaData aggregates this public data for easier access.

Do pharma payments affect prescribing quality?

Research published in JAMA Internal Medicine and other peer-reviewed journals shows a statistical association between pharmaceutical payments and prescribing patterns. However, correlation does not equal causation. Many physician-industry interactions are legitimate (research, education, advisory boards). The Sunshine Act was created to promote transparency so patients can make informed decisions.

What stands out about David Kim's pharma payment profile?

The high concentration of payment from a single company (100%) is notable. David Kim has received $47.3K in total pharma payments.

How does David Kim compare to peers in Allergy & Immunology?

For Allergy & Immunology specialists, payment profiles vary, but significant single payments, especially those related to ownership, warrant attention.

Are David Kim's pharma relationships typical for Allergy & Immunology?

The 'ownership' payment type is less common than other payment categories.

What should patients of David Kim know about these payments?

When discussing treatments with your doctor, consider asking about any financial relationships they may have with pharmaceutical companies or specific medications.

What patterns are visible in David Kim's payment history?

The single payment represents a significant portion of the total reported amount for this doctor.

Understanding This Doctor Payment Report

This transparency report for Dr. David Kim is based on data from the CMS Open Payments database, which is maintained by the Centers for Medicare and Medicaid Services under the Physician Payments Sunshine Act. Here are important things to understand:

About the Physician Payments Sunshine Act

The Physician Payments Sunshine Act, enacted as Section 6002 of the Affordable Care Act in 2010, requires pharmaceutical and medical device companies to report payments and other transfers of value to physicians and teaching hospitals to CMS. This law was designed to increase transparency in the financial relationships between the healthcare industry and medical providers.

Under this law, Dr. David Kim's pharmaceutical payments are publicly disclosed. The types of reportable transactions include consulting fees, compensated speaking or educational activities, honoraria, gifts, entertainment, food and beverages, travel and lodging, education or conference attendance, research grants, charitable contributions, royalties or licenses, current or prospective ownership interests, and direct compensation for services other than consulting.

The Open Payments data for Dr. David Kim and all other physicians can be accessed at the official CMS Open Payments website.

Related Resources

Data from CMS Open Payments (Sunshine Act). Payment does not imply wrongdoing. AI analysis is not medical or legal advice. Consult your healthcare provider about any concerns.